IndustryCompany release
Windward Bio closes $251.2M IPO and private placement, with underwriters' option exercised in full
Windward Bio Group AG · Mon 16 Nov 2026
Swiss clinical-stage biotech Windward Bio Group AG closed its Nasdaq IPO of 11,838,234 common shares at $17.00 each. The total includes the underwriters' full option of 1,544,117 shares. Gross proceeds, including a concurrent private placement, were about $251.2 million. Shares began trading on the Nasdaq Global Select Market as WWB on November 13, 2026. Windward is developing ultra-long-acting antibodies for respiratory and dermatologic diseases.
Company's press release: Windward Bio Group AG ↗
Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.
More Industry
All →
Gedeon Richter to acquire Mayne Pharma in AUD 604 million cash deal
Gedeon Richter · Mon 16 Nov 2026
Metagenomi puts hemophilia A editing candidate MGX-001 first in November 2026 deck
🇺🇸 Metagenomi Therapeutics, Inc. (MGX) · Mon 16 Nov 2026
Lifeloc Q3 revenue rises 12% as SpinDetect drug analyzer launch slips to Q4 2027
🇺🇸 Lifeloc Technologies, Inc (LCTC) · Mon 16 Nov 2026
Aytu BioPharma to be acquired by Rosemont for about $56M as EXXUA sales grow
🇺🇸 Aytu Biopharma, Inc (AYTU) · Mon 16 Nov 2026
Merck KGaA to acquire Rapid Micro Biosystems in $0.75-per-share cash tender offer
🇺🇸 Rapid Micro Biosystems, Inc. (RPID) · Mon 16 Nov 2026
Glass House Brands more than doubles Q3 revenue to $56.8M as net loss narrows
Glass House Brands Inc. (GLAS) · Mon 16 Nov 2026